SCHEMBL18289628

SCHEMBL18289628

CCOCC1O[C@@H](C)C(OCC)[C@H](O)[C@H]1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26216223 0.80 GJB2 (0.31) —
SCHEMBL20374902 0.78 SMPD1 (0.34) —
SCHEMBL14418028 0.78 ALDH1A1 (0.33) —
SCHEMBL12749244 0.78 ALDH1A1 (0.33) —
SCHEMBL15760602 0.78 FGF1 (0.31) —
SCHEMBL12017367 0.75 OGA (0.38) —
SCHEMBL18755511 0.74 — —
SCHEMBL10366417 0.74 FGF1 (0.31) —
SCHEMBL23893995 0.73 SSTR1 (0.37) —
SCHEMBL12899889 0.73 ADORA3 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160354315-A1 DOSAGE FORMS AND USE THEREOF Triastek, Inc. (CN) 2016-12-08 — — US disclosed
Send feedback